Article
EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease.
Journal of lipid research - 1 Sept 2017
Tai Leon M, Balu Deebika, Avila-Munoz Evangelina, Abdullah Laila, Thomas Riya, Collins Nicole, Valencia-Olvera Ana Carolina, LaDu Mary Jo
Abstract excerpt
Identified in 1993, APOE4 is the greatest genetic risk factor for sporadic Alzheimer's disease (AD), increasing risk up to 15-fold compared with APOE3, with APOE2 decreasing AD risk. However, the functional effects of APOE4 on AD pathology remain unclear and, in some cases, controversial. In vivo progress to understand how the human (h)-APOE genotypes affect AD pathology has been limited by the lack of a...
Topics
- Alzheimer Disease
- Animals
- Apolipoprotein E4
- Disease Models, Animal
- Humans
- Mice
- Mice, Transgenic
- Phenotype
